ICD-10 Code B41.7 | Disseminated paracoccidioidomycosis Symptoms, Diagnosis, Billing

Disseminated paracoccidioidomycosis is a systemic fungal infection caused by the dimorphic fungus Paracoccidioides brasiliensis. It primarily affects individuals in endemic regions, leading to severe pulmonary and extrapulmonary manifestations. Accurate coding with ICD-10 Code B41.7 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.

What is ICD-10 Code B41.7 for Disseminated paracoccidioidomycosis?

ICD-10 Code B41.7 represents disseminated paracoccidioidomycosis, a severe form of paracoccidioidomycosis characterized by widespread infection affecting multiple organ systems. This code should be used when documenting cases where the infection has progressed beyond the lungs, necessitating comprehensive clinical evaluation and treatment strategies.

ICD-10 Code B41.7 – Clinical Definition and Explanation of Disseminated paracoccidioidomycosis

Disseminated paracoccidioidomycosis is caused by the inhalation of spores from the fungus Paracoccidioides brasiliensis, leading to a chronic granulomatous infection. The condition can progress to involve various organs, requiring prompt medical intervention to prevent severe complications.

Key Clinical Features:

• Chronic cough and respiratory distress
• Fever and weight loss
• Skin lesions and mucosal involvement
• Lymphadenopathy and systemic symptoms

ICD-10 Code B41.7 for Disseminated paracoccidioidomycosis – SOAP Notes & Clinical Use

ICD-10 Code B41.7 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of disseminated paracoccidioidomycosis. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.

What Does ICD-10 Code B41.7 for Disseminated paracoccidioidomycosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B41.7 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of disseminated paracoccidioidomycosis. This code is vital for ensuring continuity of care, supporting billing processes, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B41.7 – Disseminated paracoccidioidomycosis

Disseminated paracoccidioidomycosis requires urgent medical attention and often hospitalization for effective management.

Antibiotic Therapy:

• Itraconazole (first-line) for 6-12 months
• Amphotericin B (alternative for severe cases)
• Fluconazole (alternative for mild cases)
• Voriconazole (considered in refractory cases)

Supportive Care:

• Symptomatic treatment for fever and pain
• Nutritional support to manage weight loss
• Monitoring for potential complications
• Psychosocial support for affected individuals

Infection Control:

• Implement standard precautions in healthcare settings
• Educate patients on hygiene practices
• Monitor for outbreaks in endemic areas
• Isolate immunocompromised patients when necessary

How to Document Symptoms of Disseminated paracoccidioidomycosis (ICD-10 B41.7) in SOAP Notes

Subjective:

• Patient reports chronic cough and fatigue
• History of weight loss and night sweats
• Complaints of skin lesions and oral ulcers
• Recent travel to endemic regions noted

Objective:

• Fever of 101°F on examination
• Lung auscultation reveals wheezing
• Skin examination shows multiple lesions
• Lymphadenopathy observed in cervical region

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Disseminated paracoccidioidomycosis (ICD-10 Code B41.7)

Assessment:

• Disseminated paracoccidioidomycosis, moderate severity
• ICD-10 Code B41.7
• Recent travel to endemic area identified as a trigger
• Immunocompromised status may contribute to severity

Plan:

• Initiate itraconazole therapy for 6-12 months
• Educate patient on medication adherence and side effects
• Schedule follow-up in 4 weeks to monitor response
• Consider referral to infectious disease specialist if no improvement

Treatment & Plan Section for ICD-10 Code B41.7 – Disseminated paracoccidioidomycosis

• First-line treatment with itraconazole for systemic infection
• Consider amphotericin B for severe cases requiring hospitalization
• Educate on lifestyle changes to improve immune function
• Regular follow-up appointments to monitor treatment efficacy

Using ICD-10 Code B41.7 for Disseminated paracoccidioidomycosis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings
• Use B41.7 in conjunction with relevant CPT codes for billing
• Maintain compliance with coding guidelines to support claims
• Document treatment plans that align with clinical guidelines

Related ICD-10 Codes Often Used with Disseminated paracoccidioidomycosis

• B41.0 – Pulmonary paracoccidioidomycosis
• B41.8 – Other forms of paracoccidioidomycosis

ICD-10 Code B41.7 in Medical Billing and Insurance for Disseminated paracoccidioidomycosis

ICD-10 Code B41.7 is critical in billing for hospital, emergency room, or infectious disease care related to disseminated paracoccidioidomycosis.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis
• Use B41.7 in appropriate settings to ensure accurate billing
• Include detailed treatment plans in patient records
• Ensure compliance with payer requirements for documentation

Common CPT Pairings: